| 翻訳と辞書 |
| Hycor Biomedical, Inc. ： ウィキペディア英語版 |
Hycor Biomedical, Inc.
Hycor Biomedical, Inc., is an American corporation specializing in the manufacture and supply of high-quality ''in vitro'' diagnostic products. Majority owned by Linden Capital Partners, Hycor Biomedical's headquarters is located in Indianapolis, Indiana, but also has offices in Garden Grove, California, and Kassel, Germany.〔http://www.hycorbiomedical.com/sites/usa/about-us/〕 Hycor Biomedical mainly produces tests and equipment relating to Allergy and Autoimmune Disease.〔http://www.hycorbiomedical.com/sites/usa/products/〕 Current equipment released by Hycor includes the HYTEC 288 Plus and the HYCOR Ultra-Sensitive EIA.
Currently, Hycor Biomedical has an estimated 14% market share〔http://www.cap.org/apps/cap.portal?_nfpb=true&cntvwrPtlt_actionOverride=%2Fportlets%2FcontentViewer%2Fshow&_windowLabel=cntvwrPtlt&cntvwrPtlt%7BactionForm.contentReference%7D=cap_today%2F1209%2F1209a_allergy_testing.html&_state=maximized&_pageLabel=cntvwr〕 in allergy testing, second to Thermo Fisher Scientific's Phadia. To increase its market share, Hycor has divested its urinalysis products, KOVA, and is focusing on improving allergy and autoimmune ''in vitro'' diagnostics.〔http://finance.yahoo.com/news/hycor-divests-urinalysis-business-increase-130000788.html〕
==Products and Services==
The most common method for allergy testing is through skin prick testing. However, this method relies on examining a patient's reaction to the exposed allergen,〔http://www.webmd.com/allergies/allergy-tests〕 and in some cases, invokes large systemic reactions.〔http://www.jiaci.org/issues/vol16issue02/1.pdf〕 With a growing need for testing younger patients〔http://www.jci.org/articles/view/18233〕 without putting them at risk, ''in vitro'' testing has become an increasingly more viable alternative.
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Hycor Biomedical, Inc.」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|